ABCL vs AAPL · rev $12.4M vs P/E 39, rev $416.16B
Abcellera Biologics Inc (ABCL) versus Apple Inc (AAPL) — a side-by-side from cached financials, not a winner call.
Abcellera Biologics Inc (ABCL) is a biotechnology company listed on US.
Apple Inc (AAPL) is a consumer electronics company listed on US. It is led by Timothy D. Cook.
Latest reported ABCL revenue for 2026-06-30 was $12.4M. Net income was -$98.6M. Revenue was up 48.7% from 2026-03-31 to 2026-06-30. ABCL currently screens at market cap $1.12B.
Latest reported AAPL revenue for 2025-09-27 was $416.16B. Net income was $112.01B. Revenue was up 6.4% from 2024-09-28 to 2025-09-27. AAPL currently screens at market cap $3.83T and trailing P/E 39.2.
ABCL currently screens at market cap $1.12B. AAPL currently screens at market cap $3.83T and trailing P/E 39.2.
Not investment advice. Open the ABCL and AAPL stock pages for the full models.
Not investment advice.